A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma
Clinical trial NCT04425070 · TERMINATED
Trial details
- NCT number
- NCT04425070
- Sponsor
- Antengene Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2025-12-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.